Document And Entity Information	3 Months Ended
Document And Entity Information	Mar. 31, 2013	May 01, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		320,648,492
Amendment Flag	false
Entity Central Index Key	0001141240
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1

Consolidated Balance Sheets (Unaudited)(Current Period) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Current assets:
Cash	$ 5,506	$ 7,162
Trade accounts receivable, net of allowance for doubtful accounts of $14 and $11, respectively	123	64
Prepaid expenses and other current assets	637	689
Total current assets	6,266	7,915
Property and equipment, net	181	161
Patents and trademarks, net	840	869
Other assets	28	28
Total assets	7,315	8,973
Current liabilities:
Accounts payable	81	154
Accrued liabilities	286	248
Accrued dividends		222
Deferred revenue	5
Convertible notes, net of debt discount of $2,167 and $4,635, respectively	1,833	2,365
Embedded conversion feature liabilities on convertible notes	2,256	3,934
Total current liabilities	4,461	6,923
Long-term liabilities
Warrant liabilities	2,256	2,766
Other long-term liabilities	856	856
Total liabilities	7,573	10,545
Common stock, $0.001 par value; 500,000,000 shares and 400,000,000 authorized at March 31, 2013 and December 31, 2012, respectively; 305,762,752 and 242,074,324 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively	306	242
Warrants	18,179	18,179
Additional paid-in capital	174,635	169,891
Accumulated deficit	(193,378)	(189,884)
Total shareholders' deficit	(258)	(1,572)
Total liabilities and shareholders' deficit	$ 7,315	$ 8,973

Consolidated Balance Sheets (Unaudited)(Current Period) (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts (in Dollars)	$ 14	$ 11
Debt discount (in Dollars)	$ 2,167	$ 4,635
Convertible, redeemable Series A Preferred Stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible, redeemable Series A Preferred Stock, shares authorized	10,000,000	10,000,000
Convertible, redeemable Series A Preferred Stock, shares issued	0	506,936
Convertible, redeemable Series A Preferred Stock, shares outstanding	0	506,936
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	500,000,000	400,000,000
Common stock, shares issued	305,762,752	242,074,324
Common stock, shares outstanding	305,762,752	242,074,324

Consolidated Statements Of Operations And Comprehensive Loss (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue
Products	$ 117	$ 183
Licensing and royalties	5	13
Total revenue	122	196
Cost of revenue, products	82	81
Gross margin	40	115
Operating expenses
Selling, marketing, general and administrative	1,314	959
Research and development	236	188
Total operating expenses	1,550	1,147
Operating loss	(1,510)	(1,032)
Change in value of warrants, gain	510
Change in value of embedded conversion feature liabilities, gain	1,678
Debt discount amortization expense	(4,034)
Interest expense	(141)	(39)
Interest income	3	4
Loss before income taxes	(3,494)	(1,067)
Income taxes	0	0
Net loss	$ (3,494)	$ (1,067)
Per common share basic and diluted:
Loss per share (in Dollars per share)	$ (0.01)	$ (0.01)
Number of weighted average shares (in Shares)	282,675,201	153,707,246

Consolidated Statement Of Shareholders' Deficit (Unaudited) (USD $) In Thousands, except Share data	Preferred Stock [Member]	Common Stock [Member]	Warrants Part of Additional Paid in Capital [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance, December 31, 2012 at Dec. 31, 2012	$ 242	$ 18,179	$ 169,891	$ (189,884)	$ (1,572)	$ (1,572)
Balance, December 31, 2012 (in Shares) at Dec. 31, 2012	506,936	242,074,324
Conversion of preferred stock	17		(17)
Conversion of preferred stock (in Shares)	(506,936)	16,896,070
Common stock issuance	47		4,427		4,474
Common stock issuance (in Shares)		46,792,358
Stock-based compensation			34		34
Restricted stock issued to officer			78		78
Dividend distribution			222		222
Net loss				(3,494)	(3,494)
Balance, March 31, 2013 at Mar. 31, 2013	$ 306	$ 18,179	$ 174,635	$ (193,378)	$ (258)	$ (258)
Balance, March 31, 2013 (in Shares) at Mar. 31, 2013		305,762,752

Consolidated Statements Of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities:
Net Loss	$ (3,494)	$ (1,067)
Adjustments to reconcile net loss to net cash provided (used in) operating activities:
Depreciation and amortization	44	50
Stock-based compensation	34	102
Resticted stock compensation issued to officer	78
Gain from change in value of warrants	(510)
Gain from change in value of embedded conversion feature liabilities	(1,678)
Debt discount amortization	4,034
Non-cash interest expense	140
Changes in operating assets and liabilities:
Trade accounts receivable	(59)	47
Prepaid expenses and other current assets	(179)	71
Other assets		16
Accounts payable and accrued expenses	(35)	12
Deferred revenue	5	(19)
Other liabilities		248
Net cash used in operating activities	(1,620)	(540)
Investing Activities:
Purchases of property and equipment	(36)
Investment in patents and trademarks		(35)
Net cash used in investing activities	(36)	(35)
Financing Activities:
Proceeds from short-term debt		750
Net cash provided by financing activities		750
Net increase (decrease) in cash	(1,656)	175
Cash at beginning of period	7,162	122
Cash at end of period	5,506	297
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Pre-installment payment of convertible debt through common stock issuance	$ 3,120

Note 1 - Description of Business

3 Months Ended

Mar. 31, 2013

Business Description and Basis of Presentation [Text Block]

1. Description of Business

Liquidmetal Technologies, Inc. (the “Company”) is a materials technology company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilize the advantages offered by amorphous alloy technology. The Company partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products. The Company believes that its proprietary bulk alloys are the only commercially viable bulk amorphous alloys currently available in the marketplace.

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain an amorphous atomic structure when they solidify, in contrast to the crystalline atomic structures that form in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. For example, in laboratory testing, zirconium-titanium Liquidmetal alloys are approximately 250% stronger than commonly used titanium alloys such as Ti-6Al-4V, but they also have some of the beneficial processing characteristics more commonly associated with plastics. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

The Company’s revenues are derived from i) selling bulk Liquidmetal alloy products, which include non-consumer electronic devices, aerospace parts, medical products, automotive components, oil and gas exploration, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue.

Note 2 - Basis of Presentation and Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2013

Basis of Presentation and Significant Accounting Policies [Text Block]

2. Basis of Presentation and Recent Accounting Pronouncements

The accompanying unaudited interim consolidated financial statements as of and for the three months ended March 31, 2013 have been prepared in accordance with accounting principles generally accepted in the United States of America (“generally accepted accounting principles”) for interim financial information and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated. Operating results for the three months ended March 31, 2013 are not necessarily indicative of the results that may be expected for any future periods or the year ending December 31, 2013. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company's 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 26, 2013.

Revenue Recognition

Revenue is recognized pursuant to applicable accounting standards including FASB ASC Topic 605 (“ASC 605”), Revenue Recognition. ASC 605 summarizes certain points of the SEC staff’s views in applying generally accepted accounting principles to revenue recognition in financial statements and provides guidance on revenue recognition issues in the absence of authoritative literature addressing a specific arrangement or a specific industry.

The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the sales price is fixed or determinable, (iv) collection is probable and (v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of the sales and prototyping of Liquidmetal mold and bulk alloys as well as licensing and royalties for the use of the Liquidmetal brand and bulk Liquidmetal alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are one time fees upon the granting of the license are recognized when (i) the license term begins in a manner consistent with the nature of the transaction and the earnings process, (ii) collectability is reasonably assured or upon receipt of an upfront fee, and (iii) all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Fair Value Measurements

The estimated fair values of amounts reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, trade receivables, prepaid expenses and other current assets, accounts payable, and accrued liabilities approximate their carrying value due to their short maturities. The fair value of non-current assets and liabilities approximate their carrying value unless otherwise stated. The carry amounts reported for debt obligations approximate fair value due to the effective interest rate of these obligations reflecting the Company’s current borrowing rate.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level 1 —

Quoted prices in active markets for identical assets or liabilities;

Level 2 —

Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3 —

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has one Level 2 financial instrument, warrants that are recorded at fair value on a periodic basis. Warrants are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such warrants is estimated using the Black-Scholes option pricing model. The foregoing warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815 (see note 8).

The Company has one Level 3 financial instrument, an embedded derivative that is recorded at fair value on a periodic basis. The embedded derivative is evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing embedded derivatives. The fair value of such embedded derivative is estimated using the Monte Carlo simulation model. The foregoing embedded derivative has certain anti-dilution and exercise price reset provisions which qualify the embedded derivative to be classified as a liability under FASB ASC 815 (see note 7).

As of March 31, 2013, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3

Embedded conversion feature liability		-		-		-	$	2,256
Warrant liabilities		-		-	$	2,256		-

Recent Accounting Pronouncements

In June 2011, the FASB issued guidance regarding the presentation of comprehensive income. The new guidance eliminates the option to report other comprehensive income and its components in the statement of changes in equity. Instead, an entity is required to present either a continuous statement of net income and other comprehensive income or two separate but consecutive statements. The updated guidance is effective on a retrospective basis for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2011. The Company adopted the guidance beginning on January 1, 2012.

In May 2011, the FASB issued additional guidance on fair value measurements that clarifies the application of existing guidance and disclosure requirements, changes certain fair value measurement principles and requires additional disclosures about fair value measurements. The updated guidance is effective on a prospective basis for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2011. The Company adopted the guidance beginning on January 1, 2012.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Note 3 - Significant Transactions

3 Months Ended

Mar. 31, 2013

Significant Transactions [Text Block]

3. Significant Transactions

July 2012 Private Placement

On July 2, 2012, the Company entered into a private placement transaction (the “July 2012 Private Placement”) for $12,000 in principal amount of senior convertible notes due on September 1, 2013. The notes are convertible at any time at the option of the holders, into shares of the Company’s common stock at a conversion price of $0.352 per share. In the event that the Company issues or sells shares of the Company’s common stock for a price per share that is less than the conversion price then in effect, the conversion price then in effect will be decreased to such lower price, subject to customary exceptions. The notes bear interest at 8% per annum and are payable in twelve equal monthly installments of principal and interest beginning on October 1, 2012. Each monthly installment payment may be made in cash, shares of the Company’s common stock, or a combination thereof. If paid in shares, such shares will be valued at the lower of (i) the then applicable conversion price or (ii) a price that is 87.5% of the arithmetic average of the ten (or in some cases fewer) lowest weighted average prices of the Company’s common stock during the twenty trading day period ending two trading days before the payment date or the date on which the Company elects to pay in shares, whichever is lower (the “Measurement Period”). The Company’s ability to make such payments with shares of the Company’s common stock will be subject to certain conditions including (i) a minimum of $250 in average daily trading volume during the Measurement Period, (ii) a minimum of $150 in daily trading volume during each day during the Measurement Period, with certain exceptions, and (iii) the effectiveness of a resale registration statement with respect to the shares. As of March 31, 2013, the Company issued 96,963,776 shares of common stock in satisfaction of the first eight monthly installments under the July 2012 Private Placement (see note 7).

As a part of the July 2012 Private Placement, the Company issued warrants to purchase 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share, and such warrants first became exercisable within six months of the issuance date thereof. In the event that the Company issues or sells shares of the Company’s common stock at a price per share that is less than the exercise price then in effect, the exercise price of the warrants will be reduced based on a weighted-average formula. In addition, on the two year anniversary of the issuance date, the then applicable exercise price may be reset to equal the lesser of (i) the then current exercise price or (ii) 87.5% of the arithmetic average of the ten lowest weighted average prices of the common stock during the twenty trading day period ending two trading days immediately preceding the reset date. All of the warrants will expire on July 2, 2017 (see note 8).

June 2012 Visser MTA Agreement

On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA Agreement”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing.

Under the manufacturing and service component of the Visser MTA Agreement, the Company has agreed to engage Visser as a perpetual, exclusive manufacturer of non-consumer electronic products and to not, directly or indirectly, conduct manufacturing operations, subcontract for the manufacture of products or components or grant a license to any other party to conduct manufacturing operations, except for certain limited exceptions. Further, the Company has agreed to sublicense to Visser, on a fully-paid up, royalty-free, irrevocable, perpetual, worldwide basis, all intellectual property rights held by the Company. In addition, Visser has a right of first refusal over any proposed transfer by the Company of its technology pursuant to any license, sublicense, sale or other transfer, other than a license to a machine or alloy vendor.

Under the financing component of the Visser MTA Agreement, the Company issued and sold to Visser in a private placement transaction (i) 30,000,000 shares of common stock at a purchase price of $0.10 per share resulting in proceeds of $3,000, (ii) warrants to purchase 15,000,000 shares of common stock (subsequently increased to 16,861,416 warrants for anti-dilution impact, see note 8) at an original exercise price of $0.22 per share (subsequently reduced to $0.20 for anti-dilution impact, see note 8) which expire on June 1, 2017 and (iii) a secured convertible promissory note (the “Promissory Note”) in the aggregate principal amount of up to $2,000 which was convertible into shares of common stock at a conversion rate of $0.22 per share. The Promissory Note was issued pursuant to a $2,000 loan facility made available by Visser, but no borrowings were made by the Company under this loan facility, and the deadline for making borrowings under the facility expired on November 15, 2012. All of the shares of common stock issuable upon exercise of the warrants are subject to a lock-up period through December 31, 2016.

The warrants under the Visser MTA Agreement contain certain anti-dilution and exercise price reset provisions which results in liability accounting under FASB ASC 815 (see note 8). In relation to the financing cost component to the Visser transaction, the Company performed a prorated allocation of the fair value of the warrants on the convertible promissory note and the common stock based on their relative fair values. The Company capitalized deferred financing costs in relation to the convertible promissory note totaling $1,355 and offset additional paid-in capital for $2,905 in relation to the warrant. The Company assessed the value of the deferred financing costs as of the quarter ended June 30, 2012 and determined that the value was impaired due to the limitations on the Company’s ability to request for advances as discussed above. Therefore, the Company expensed the deferred financing costs totaling $1,355 as of the quarter ended June 30, 2012.

In connection with the Visser MTA Agreement, the Company performed a valuation analysis of the manufacturing service and financing components of the Visser MTA Agreement as part of the bundled contract. The Company has assessed and determined that while these components may have market values on a standalone basis, the values of the manufacturing component and sublicense component were deemed immaterial for accounting purposes. Further, the Company’s weighted average market stock price was approximately $0.31 per share at the time of share issuances to Visser. As the actual share purchase price related to the financing component of the Visser MTA Agreement was $0.10 per share, the $0.21 per share difference was treated as manufacturing contract costs and $6,300 was expensed as operating expenses during the second quarter ended June 30, 2012.

On January 17, 2012, February 27, 2012, March 28, 2012 and April 25, 2012, the Company issued 8% unsecured, bridge promissory notes to Visser that were due upon demand in the amounts of $200, $200, $350 and $300, respectively. The aggregate principal amount of $1,050 and accrued interest under the bridge promissory notes were all paid off on June 1, 2012 by utilizing a portion of the proceeds received under the financing component of the Visser MTA Agreement.

Apple License Transaction

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work.

Under the agreements relating to the license transaction with Apple, the Company is obligated to contribute all intellectual property that it developed through February 2012 (and subsequently amended to extend through February 2014) to CIP. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

Other License Transactions

On January 31, 2012, the Company and Engel Austria Gmbh (“Engel”) entered into a Supply and License Agreement for a five year term whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees.

On November 16, 2011, the Company and Materion Brush Inc. (“Materion”) entered into a Development Agreement to evaluate, analyze and develop amorphous alloy feedstock to be supplied in commercial quantities. Further, on June 17, 2012, the Company entered into a Sales Representation Agreement with Materion whereby Materion shall promote the sale of Liquidmetal’s products for certain commissions. This agreement is for a two year initial term with annual, automatic renewals. To date, there have been no commission payments related to this agreement.

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. Liquidmetal Technologies owns 79% of the outstanding common stock in Liquidmetal Golf.

In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a perpetual non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Note 4 - Liquidity and Capital Resources

3 Months Ended

Mar. 31, 2013

Liquidityand Capital Resource Disclosure [Text Block]

4. Liquidity and Capital Resources

The Company’s cash used in operations was $1,620 for the three months ended March 31, 2013, while cash used in operations was $540 for the three months ended March 31, 2012. The Company’s cash used in investing activities was $36 for the three months ended March 31, 2013. The Company had no financing activities during the three months ended March 31, 2013. As of March 31, 2013, the Company’s cash balance was $5,506.

On July 2, 2012, the Company entered into definitive agreements relating to a private placement of $12,000 in principal amount of Senior Convertible Notes due on September 1, 2013 and Warrants to the purchasers of such Senior Convertible Notes giving such purchasers the right to purchase up to an aggregate of 18,750,000 shares of the Company’s common stock at an exercise price of $0.384 per share. At March 31, 2013, the outstanding principal under the Senior Convertible Notes was $4,000 (see note 3). There was no unpaid accrued interest as of March 31, 2013.

The Company does not believe that the Company has the financial ability to make all payments on the Senior Convertible Notes in cash when due. Accordingly, the Company intends to make such payments in shares of our common stock to the greatest extent possible. Because the price at which the Company will issue shares to the notes will vary with the market price of the Company’s common stock, the repayment of the Senior Convertible Notes with shares of the Company’s common stock will continue to be highly dilutive. The Company is able to make such payments in shares of common stock only if the holders of the notes consent with the method of payment.

The Company anticipates that the Company’s current capital resources, together with income from operations, will be sufficient to fund the Company’s operations through the end of 2013. The Company has a relatively limited history of producing bulk amorphous alloy components and products on a mass-production scale. Furthermore, Visser’s ability to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. Such factors will likely require that the Company raise additional funds to support the Company’s operations beyond 2013. There is no assurance that the Company will be able to raise such additional funds on acceptable terms, if at all. If the Company raises additional funds by issuing securities, existing stockholders may be diluted. If funding is insufficient at any time in the future, the Company may be required to alter or reduce the scope of the Company’s operations or to cease operations entirely. As a result of these and other factors, the Company’s independent registered public accounting firm has indicated, in their audit opinion on the Company’s 2012 consolidated financial statements, that there is substantial doubt about the Company’s ability to continue as a going concern.

Note 6 - Patents and Trademarks, net

3 Months Ended

Mar. 31, 2013

Intangible Assets Disclosure [Text Block]

6. Patents and Trademarks, net

Net Patents and trademarks totaled $840 and $869 as of March 31, 2013 and December 31, 2012, respectively, and it primarily consists of purchased patent rights and internally developed patents.

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreements.

In addition to the purchased and licensed patents, the Company has internally developed patents. Internally developed patents include legal and registration costs incurred to obtain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

The Company amortizes capitalized patents and trademarks over an average of 10 to 17 year periods. Amortization expense for Patents and trademarks was $33 and $38 for the three months ended March 31, 2013 and 2012, respectively.

Note 9 - Other Long-term Liabilities	3 Months Ended
Note 9 - Other Long-term Liabilities	Mar. 31, 2013
Other Liabilities Disclosure [Text Block]	9. Other Long-term Liabilities Other long-term liabilities balance was $856 as of March 31, 2013 and December 31, 2012, and consists of long-term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or write-off.

Note 13 - Commitments and Contingencies	3 Months Ended
Note 13 - Commitments and Contingencies	Mar. 31, 2013
Commitments and Contingencies Disclosure [Text Block]	13. Commitments and Contingencies The Company leases its office and warehouse facility under a lease agreement that expires on April 30, 2016. Rent payments are subject to escalations through the end of the lease term. Rent expense was $49 and $50 for the three months ended March 31, 2013 and 2012, respectively.

Note 1 - Description of Business (Detail)	9 Months Ended
Note 1 - Description of Business (Detail)	Sep. 30, 2012
Percentages of stronger than zirconium titanium Liquidmetal alloys	250.00%

Note 2 - Basis of Presentation and Recent Accounting Pronouncements (Detail) - Fair Value of Items Measured on a Recurring Basis (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013
Fair Value, Inputs, Level 2 [Member]
Warrant liabilities	$ 2,256
Fair Value, Inputs, Level 3 [Member]
Embedded conversion feature liability	$ 2,256

Note 5 - Prepaid Expenses and Other Current Assets (Detail) (USD $)	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2012	Jul. 02, 2012
Deferred Finance Costs, Net	$ 187,000		$ 1,033,000
Deferred issuance costs amortization period	14 months
Amortization of Deferred Charges	212,000
Stock Issuance Costs		$ 399

Note 7 - Convertible Note and Embedded Conversion Feature Liability (Detail) - Convertible Note, Net of Debt Discount (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Jul. 02, 2012
Beginning Balance - December 31, 2012		$ 12,000
Beginning Balance - December 31, 2012	2,365
Ending Balance - March 31, 2013		12,000
Ending Balance - March 31, 2013	1,833
Amortization	4,034
Convertible Notes Payable [Member]
Beginning Balance - December 31, 2012	7,000
Beginning Balance - December 31, 2012	(4,635)
Beginning Balance - December 31, 2012	2,365
Ending Balance - March 31, 2013	4,000
Ending Balance - March 31, 2013	(2,167)
Ending Balance - March 31, 2013	1,833
Installment Payments in Shares	(3,000)
Amortization	$ 2,468

Note 7 - Convertible Note and Embedded Conversion Feature Liability (Detail) - Embedded Derivatives Classified as Embedded Conversion Feature Liability (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Dec. 31, 2012
Beginning Balance - January 1, 2013	$ 3,934
Ending Balance - March 31, 2013	2,256	3,934
Change in value of embedded conversion feature liability, gain	$ (1,678)

Note 8 - Warrant Liability (Detail) (USD $)			3 Months Ended	9 Months Ended		3 Months Ended			0 Months Ended
Note 8 - Warrant Liability (Detail) (USD $)	Mar. 31, 2013	Dec. 31, 2012	Mar. 31, 2013 Visser MTA Agreement [Member]	Mar. 31, 2013 Visser MTA Agreement [Member]	Jun. 30, 2012 Visser MTA Agreement [Member]	Mar. 31, 2013 July 2, 2012 Private Placement [Member]	Mar. 31, 2013 Warrants valued as liability [Member]	Jul. 02, 2012 Private Placement [Member] July 2, 2012 Private Placement [Member]	Jul. 02, 2012 Private Placement [Member]
Class of Warrant or Right, Outstanding					15,000,000
Investment Warrants, Exercise Price (in Dollars per share)				$ 0.22					$ 0.384
Original valuation - June & July 2012 (in Dollars)				$ 4,260,000					$ 5,053,000
Class of warrant or right adjusted exercise price of warrants or rights (in Dollars per Item)	0.20	0.21
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	16,861,416	15,776,632					35,611,416	18,750,000
Warrants that were Exercised			1,105			1,151
Fair Value Assumptions, Expected Term			4 years 62 days			4 years 3 months
Fair Value Assumptions, Expected Volatility Rate			152.00%			152.00%
Fair Value Assumptions, Risk Free Interest Rate			0.77%			0.77%
Fair Value Assumptions, Expected Dividend Rate			0.00%			0.00%
Change in Warrant Valuation, Gain (loss) (in Dollars)			$ 155	$ 155		$ 355
Warrants to purchase shares	65,390,973	64,306,189

Note 9 - Other Long-term Liabilities (Detail) (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
Other Liabilities, Noncurrent	$ 856	$ 856
Period for outstanding liability	5 years

Note 10 - Stock Compensation Plan (Detail)	3 Months Ended
Note 10 - Stock Compensation Plan (Detail)	Mar. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	12,807,500	330,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	12,597,500
2002 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	3,342,000	3,392,000

Note 11 - Shareholders' Deficit (Detail) (USD $)	1 Months Ended	3 Months Ended						3 Months Ended		9 Months Ended			0 Months Ended	1 Months Ended					0 Months Ended	1 Months Ended			3 Months Ended
Note 11 - Shareholders' Deficit (Detail) (USD $)	Dec. 31, 2012	Mar. 31, 2013	Feb. 28, 2013 Original Amount (Member) Certificate of Incorporation (Member)	Feb. 28, 2013 New Amount (Member) Certificate of Incorporation (Member)	Apr. 30, 2009 Convertible series A1 Preferred Stock [Member]	Apr. 30, 2009 Convertible series A2 Preferred Stock [Member]	Jun. 30, 2012 Common Stock [Member] Visser MTA Agreement [Member]	Mar. 31, 2013 Common Stock [Member]	Dec. 31, 2012 Warrant [Member]	Sep. 30, 2012 Series A Preferred Stock [Member]	Mar. 31, 2013 Series A Preferred Stock [Member]	Dec. 31, 2012 Series A Preferred Stock [Member]	Feb. 28, 2013 Convertible series A1 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A1 Preferred Stock [Member]	Mar. 31, 2013 Convertible series A1 Preferred Stock [Member]	Dec. 31, 2012 Convertible series A1 Preferred Stock [Member]	Oct. 31, 2009 Convertible series A1 Preferred Stock [Member]	Apr. 30, 2009 Convertible series A1 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A2 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A2 Preferred Stock [Member]	Mar. 31, 2013 Convertible series A2 Preferred Stock [Member]	Dec. 31, 2012 Convertible series A2 Preferred Stock [Member]	Mar. 31, 2013 July 2012 Private Placement senior convertible note [Member]
Common Stock, Shares, Issued	242,074,324	305,762,752					30,000,000
number of periodic payments																							eight
Stock Issued During Period, Shares, New Issues								46,792,358															96,963,776
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																							$ 0.0888
Conversion of Stock, Shares Converted (in Shares)										506,936			28,928	58,600					109,528	260,710
Convertible Preferred Stock, Shares Issued upon Conversion										16,896,070	16,896,070
Common Stock, Shares Authorized	400,000,000	500,000,000	400,000,000	500,000,000
Preferred Stock, Shares Issued	506,936	0				2,625,000											180,000	500,000
Convertible preferred stock conversion price (in Dollars per share)					$ 5.00	$ 5.00									$ 0.10						$ 0.22
Preferred Stock, Shares Outstanding	506,936	0										506,936				105,231						401,705
Preferred Stock, Value, Issued (in Dollars)	$ 0
Dividends, Preferred Stock (in Dollars)	222,000
Adjustments to Additional Paid in Capital, Reclassification of Accured Preferred Stock Dividends (in Dollars)		222
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	15,776,632	16,861,416							29,779,557
Warrants classified equity was reduced (in Dollars)	$ 18,179,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		0.49
Equity Method Investment, Ownership Percentage		79.00%

Note 12 - Loss Per Common Share (Detail) (USD $)	1 Months Ended	3 Months Ended
Note 12 - Loss Per Common Share (Detail) (USD $)	Dec. 31, 2012	Mar. 31, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,722,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		0.49
Stock Options [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)	$ 0.09	$ 0.08
Stock Options [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)	$ 5.00	$ 4.57
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		16,149,500
Warrant [Member] \| Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	0.21	0.20
Warrant [Member] \| Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	0.49	0.49
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	64,306,189	65,390,973

Note 13 - Commitments and Contingencies (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating Leases, Rent Expense, Net	$ 49	$ 50

Note 14 - Related Party Transactions (Detail) (USD $) In Thousands, except Share data, unless otherwise specified	0 Months Ended	1 Months Ended									1 Months Ended		3 Months Ended			12 Months Ended	0 Months Ended	12 Months Ended	0 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended
	Feb. 28, 2013	Feb. 28, 2013	Dec. 31, 2012	Apr. 25, 2012	Jun. 30, 2012 Unsecured bridge promissory note [Member]	Jun. 02, 2012 Unsecured bridge promissory note [Member]	Apr. 25, 2012 Unsecured bridge promissory note [Member]	Mar. 28, 2012 Unsecured bridge promissory note [Member]	Feb. 27, 2012 Unsecured bridge promissory note [Member]	Jan. 17, 2012 Unsecured bridge promissory note [Member]	Aug. 31, 2012 Innovative Materials Group [Member]	Aug. 30, 2011 Innovative Materials Group [Member]	Mar. 31, 2013 Innovative Materials Group [Member]	Mar. 31, 2012 Innovative Materials Group [Member]	Aug. 05, 2011 Innovative Materials Group [Member]	Dec. 31, 2012 Former Chairman [Member]	Feb. 02, 2012 Chief Financial Officer [Member] Convertible series A1 Preferred Stock [Member]	Dec. 31, 2009 Chief Financial Officer [Member] Convertible series A1 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A1 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A1 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A2 Preferred Stock [Member]	Feb. 28, 2013 Convertible series A2 Preferred Stock [Member]	Apr. 25, 2012 Unsecured bridge promissory note [Member]	Mar. 28, 2012 Unsecured bridge promissory note [Member]	Feb. 27, 2012 Unsecured bridge promissory note [Member]	Jan. 17, 2012 Unsecured bridge promissory note [Member]
Sale of Stock, Consideration Received Per Transaction											$ 720
Notes, Loans and Financing Receivable, Gross, Current			200												200
Notes receivable interest rate during period												8.00%
Royalty Revenue													0	12
Debt Instrument, Increase, Accrued Interest			21
License Costs			221
Asset Impairment Charges			221
Legal Fees																2
Conversion of Stock, Shares Converted (in Shares)																	10,000		28,928	58,600	109,528	260,710
Conversion of Stock, Shares Issued (in Shares)	4,626,840	10,387,883																565,344
Debt Instrument, Interest Rate, Stated Percentage				8.00%				8.00%	8.00%	8.00%													8.00%	8.00%	8.00%	8.00%
Debt Instrument, Face Amount					$ 1,050	$ 1,050	$ 300	$ 350	$ 200	$ 200